Lantern Pharma GAAP EPS of -$0.42 beats by $0.07 Lantern Pharma GAAP EPS of -$0.42 beats by $0.07 Post ContentltrnRead More You might also be interested in reading Dot AI prepares for February IPO. May 15, 2025 In Mainstream ← Previous post Next post →